查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2032519

鴉片類藥物市場報告：按產品類型、應用、分銷管道和地區分類（2026-2034 年）

Opioids Market Report by Product Type, Application, Distribution Channel, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3個工作天內

價格

2025年全球鴉片類藥物市場規模達231億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到292億美元，2026年至2034年的複合年成長率為2.55%。慢性疼痛發病率上升、人口老化、癌症診斷率增加、醫療保健服務可近性提高、持續的研發投入、消費者意識增強以及有利的政府法規是推動市場成長的主要因素。

鴉片類藥物市場趨勢：

慢性疼痛盛行率增加

全球慢性疼痛盛行率的不斷上升是鴉片類藥物產業成長的主要驅動力。 2021年，超過20.9%的美國成年人（5,160萬人）患有慢性疼痛，其中6.9%（1,710萬人）報告患有嚴重慢性疼痛，嚴重影響了他們的日常生活。數百萬人飽受慢性疼痛的折磨，這些疼痛通常由關節炎、背痛和神經病變等引起，因此，有效的疼痛管理療法的需求日益成長。根據美國疾病管制與預防中心（CDC）統計，2019年至2021年間，約有5,320萬美國人（佔總人口的21.2%）被醫師診斷為關節炎。因此，由於鴉片類藥物在治療嚴重疼痛方面療效顯著，醫療保健專業人員正在開立此類藥物。

人口老化的進程

鴉片類藥物產業的成長主要受人口老化的影響。 2022年，全球65歲以上人口達7.71億，約佔全球總人口的10%。在印度，2022年60歲及以上人口為1.49億，約佔總人口的10.5%。此外，歐盟人口預計到2023年將達到4.488億，其中超過五分之一（21.3%）的人口年齡將在65歲及以上。老年人更容易因骨關節炎和癌症等與老齡化相關的疾病而遭受慢性疼痛的困擾，這增加了對疼痛治療方案的需求。在美國，據估計有47%的65歲及以上成年人被診斷出患有關節炎。骨關節炎是印度第二大常見風濕病，也是最常見的關節疾病，盛行率在 22% 至 39% 之間。大約 45% 的 65 歲及以上女性會出現症狀，70% 的 65 歲及以上人會出現影像學觀察。

全球癌症發生率不斷上升

癌症診斷率的上升，尤其是在新興經濟體，正在推動對鴉片類藥物的需求。根據國際癌症研究機構（IARC）估計，2022年新增癌症病例2000萬例，死亡970萬例。癌症確診後的五年存活率估計為5350萬。此外，大約五分之一的人一生中會罹患癌症，九分之一的男性和十二分之一的女性會死於癌症。癌症患者常常遭受劇烈疼痛，而鴉片類藥物是癌症疼痛管理的重要組成部分。隨著全球癌症發生率的上升，對有效疼痛管理的需求也在不斷成長，這進一步推動了鴉片類藥物產業的擴張。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球鴉片類藥物市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品類型分類

  • 可待因
  • Fentanyl
  • 梅塔頓
  • 羥考酮
  • 氫可酮
  • 氫可酮

第7章 市場區隔：依應用領域分類

  • 疼痛管理
  • 咳嗽的治療
  • 腹瀉治療
  • 其他

第8章 市場區隔：依分銷通路分類

  • 醫院藥房
  • 零售藥房
  • 藥局
  • 網路商店
  • 其他

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Boehringer Ingelheim International GmbH
    • Hikma Pharmaceuticals PLC
    • Mallinckrodt plc
    • Pfizer Inc.
    • Purdue Pharma LP
    • Sanofi SA
    • Sun Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd.
Product Code: SR112026A4559

The global opioids market size reached USD 23.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 29.2 Billion by 2034, exhibiting a growth rate (CAGR) of 2.55% during 2026-2034. The rising incidence of chronic pain conditions, increasing elderly population, increase in cancer diagnoses, improved access to healthcare services, ongoing research and development (R&D) efforts, escalating consumer awareness, and favorable government regulations are some of the major factors propelling the market.

OPIOIDS MARKET ANALYSIS:

  • Major Market Drivers: The opioid market analysis identifies important factors, such as chronic pain, growing elderly population, and increasing prevalence of diseases including arthritis and cancer.
  • Key Market Trends: Based on the opioid market forecast, the major trends include the ongoing shift towards the development of abuse-deterrent formulations (ADF) of opioids to minimize the risk of addiction.
  • Geographical Trends: The opioid market is dominated by North America due to high prescription rates, a well-established healthcare system, and the prevalence of chronic pain conditions among its population. Other regions are also experiencing growth due to increased healthcare expenditure, awareness of pain management options, and infrastructure expansion.
  • Competitive Landscape: Some of the major market players in the opioids industry include Boehringer Ingelheim International GmbH, Hikma Pharmaceuticals PLC, Mallinckrodt plc, Pfizer Inc., Purdue Pharma L.P., Sanofi S.A., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd., among many others.
  • Challenges and Opportunities: The opioid market faces challenges, such as stricter regulatory controls and increased demand for non-opioid pain management options. However, there is an opportunity to develop and market new opioid formulations that are effective and less likely to lead to abuse and addiction.

OPIOIDS MARKET TRENDS:

Increasing prevalence of chronic pain

The increasing incidence of chronic pain throughout the world is a primary driver of opioid industry growth. In 2021, over 20.9% of U.S. adults (51.6 million) suffered chronic pain, while 6.9% (17.1 million) reported high-impact chronic pain (i.e., pain that significantly limits daily activities). Millions of people suffer from chronic pain, which is commonly caused by ailments, such as arthritis, back difficulties, or neuropathic disorders, boosting the use of effective pain management treatments. In 2019-2021, around 53.2 million US individuals (21.2%) had arthritis diagnosed by a doctor, according to the Center for Disease Control and Prevention (CDC). As a result, opioids are prescribed by healthcare practitioners because of their effectiveness in treating severe pain.

Growing geriatric population

The opioids industry is driven by the growing geriatric population. In 2022, there were 771 million persons aged 65 and over, accounting for about 10% of the global population. In 2022, 14.9 crore people in India were recorded to be 60 years or older, accounting for approximately 10.5% of the total population. In addition, the population of the European Union (EU) was predicted to be 448.8 million in 2023, with more than one-fifth (21.3%) of it aged 65 and more. Geriatric individuals are more likely to endure chronic pain due to age-related disorders, such as degenerative joint disease and cancer. This has raised the need for pain treatment choices. It is estimated that among adults aged 65 and older, 47% are diagnosed with arthritis in the USA. Also, osteoarthritis is the second most common rheumatologic problem, and it is the most frequent joint disease with a prevalence of 22% to 39% in India. Nearly, 45% of women over the age of 65 years have symptoms while radiological evidence is found in 70% of those over 65 years.

Rising cancer rates across the globe

The increasing rate of cancer diagnoses, particularly in emerging nations, is fueling the demand for opioids. The International Agency for Research on Cancer (IARC) estimated that 20 million new cancer cases and 9.7 million deaths occurred in 2022. The expected number of persons who survived 5 years after a cancer diagnosis was 53.5 million. Furthermore, around one in every five persons develops cancer during their lifetime, with one in every nine men and one in every twelve women dying from the condition. Cancer patients frequently experience significant pain, and opioids are a key component of cancer pain therapy. As cancer rates increase internationally, so does the demand for effective pain management, driving the opioid industry expansion.

OPIOIDS MARKET SEGMENTATION:

Breakup by Product Type:

  • Codeine
  • Fentanyl
  • Methadone
  • Oxycodone
  • Morphine
  • Hydrocodone

Oxycodone accounts for the majority of the market share

According to the opioids market statistics, oxycodone has emerged as a dominant product type owing to its potent pain-relieving properties, which make it highly effective in managing severe pain, including post-operative and cancer-related pain. Physicians often prescribe oxycodone when other pain management options prove insufficient. Moreover, the pharmaceutical industry has invested significantly in the development of extended-release formulations of oxycodone, offering prolonged pain relief with fewer dosing intervals. Additionally, oxycodone's versatility allows for various administration routes, including oral tablets, capsules, and intravenous formulations, catering to diverse patient needs, which, in turn, is propelling its adoption.

Breakup by Application:

  • Pain Management
  • Cough Treatment
  • Diarrhea Treatment
  • Others

Pain management holds the largest share of the industry

Based on the opioid market trends, pain management accounted for the largest market share. Opioid's fundamental role in the healthcare sector and the increasing recognition of the importance of effectively addressing pain is fueling its adoption in pain management applications. Pain refers to a pervasive and complex medical issue affecting millions of individuals worldwide, and opioids are considered a crucial component in managing moderate to severe pain, especially in acute and chronic pain conditions, post-surgical recovery, and cancer-related pain. The sheer prevalence of pain-related conditions owing to the burgeoning geriatric population and the rising incidence of cancer diagnoses, thereby creating a sustained demand for effective pain relief methods, is bolstering the opioids market share.

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Stores
  • Others

According to the opioids market overview, hospital pharmacies represent a critical distribution channel as these settings are the first encounters of opioid prescriptions for patients, especially after surgeries or for acute pain management. They ensure controlled distribution and use, providing a direct link between the prescription and administration of opioids under medical supervision.

As per the opioids market analysis, retail pharmacies serve as the most accessible point for patients to fill opioid prescriptions for chronic pain management. They cater to the ongoing needs of patients outside the hospital setting, facilitating the continuity of care prescribed by healthcare providers. Retail pharmacies offer widespread availability, convenience, and, in some regions, counseling services to ensure safe use, boosting the opioid market revenue.

According to the opioids market report, drug stores offer a broader shopping experience with a particular focus on health. They provide a convenient option for patients to access their medications along with other healthcare products. The role of drug stores in the opioid industry underscores the balance between accessibility to necessary medications and the responsibility to limit access to prescription drugs to prevent abuse.

Online pharmacies represent a growing segment in the opioid market, offering patients convenience and lower prices for their medications. Moreover, rapid advancements in digital health technologies and changing consumer behaviors are favoring the shift toward online shopping. Along with this, online pharmacies increase access to pain management solutions in underserved or rural areas.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest opioids market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for opioids.

As per the opioids market outlook, The North American region dominated the market share due to several factors, including a high prevalence of chronic pain conditions, such as back pain and osteoarthritis, an aging population, and the widespread use of opioids in pain management. In addition to this, improved healthcare infrastructure and increased awareness of pain management options have led to higher opioid prescription rates, positively impacting the opioid market demand. Moreover, specialized addiction treatment centers and pharmacies have emerged as distribution channels, addressing the demand for these medications. Furthermore, evolving regulations and prescribing practices, influenced by stricter guidelines and prescription monitoring programs, are influencing the opioid market growth.

COMPETITIVE LANDSCAPE:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the opioids industry include Boehringer Ingelheim International GmbH, Hikma Pharmaceuticals PLC, Mallinckrodt plc, Pfizer Inc., Purdue Pharma L.P., Sanofi S.A., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., etc. ()
  • According to recent research that analyzes the opioid market's recent developments, it has been found that leading pharmaceutical companies are investing heavily in research and development (R&D) to develop innovative opioid formulations. These efforts focus on creating opioids with improved safety profiles, reduced potential for abuse, and enhanced efficacy in pain management. The goal is to provide healthcare professionals with more effective and safer treatment options. Moreover, opioid market companies are closely monitoring and complying with evolving regulations and guidelines related to opioid prescribing, distribution, and usage. They are working to ensure that their products meet the highest safety and quality standards while adhering to stringent regulatory requirements. All these efforts are shaping the opioids market's recent price and opportunities.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How has the global opioids market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global opioids market?
  • What is the impact of each driver, restraint, and opportunity on the global opioids market?
  • What are the key regional markets?
  • Which countries represent the most attractive opioids market?
  • What is the breakup of the market based on the product type?
  • Which is the most attractive product type in the opioids market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the opioids market?
  • What is the breakup of the market based on the distribution channel?
  • Which is the most attractive distribution channel in the opioids market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global opioids market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Opioids Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Codeine
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Fentanyl
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Methadone
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Oxycodone
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Morphine
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Hydrocodone
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Pain Management
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cough Treatment
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Diarrhea Treatment
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Drug Stores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Online Stores
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Boehringer Ingelheim International GmbH
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Hikma Pharmaceuticals PLC
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Mallinckrodt plc
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Pfizer Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Purdue Pharma L.P.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Sanofi S.A.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Sun Pharmaceutical Industries Ltd.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Teva Pharmaceutical Industries Ltd.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Opioids Market: Major Drivers and Challenges
  • Figure 2: Global: Opioids Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Opioids Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Opioids Market: Breakup by Product Type (in %), 2025
  • Figure 5: Global: Opioids Market: Breakup by Application (in %), 2025
  • Figure 6: Global: Opioids Market: Breakup by Distribution Channel (in %), 2025
  • Figure 7: Global: Opioids Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Opioids (Codeine) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Opioids (Codeine) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Opioids (Fentanyl) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Opioids (Fentanyl) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Opioids (Methadone) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Opioids (Methadone) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Opioids (Oxycodone) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Opioids (Oxycodone) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Opioids (Morphine) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Opioids (Morphine) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Opioids (Hydrocodone) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Opioids (Hydrocodone) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Opioids (Pain Management) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Opioids (Pain Management) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Opioids (Cough Treatment) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Opioids (Cough Treatment) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Opioids (Diarrhea Treatment) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Opioids (Diarrhea Treatment) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Opioids (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Opioids (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Opioids (Hospital Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Opioids (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: Opioids (Retail Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: Opioids (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Global: Opioids (Drug Stores) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Global: Opioids (Drug Stores) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Global: Opioids (Online Stores) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Global: Opioids (Online Stores) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Global: Opioids (Other Distribution Channels) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Global: Opioids (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: North America: Opioids Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: North America: Opioids Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: United States: Opioids Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: United States: Opioids Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Canada: Opioids Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Canada: Opioids Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Asia-Pacific: Opioids Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Asia-Pacific: Opioids Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: China: Opioids Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: China: Opioids Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Japan: Opioids Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Japan: Opioids Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: India: Opioids Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: India: Opioids Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: South Korea: Opioids Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: South Korea: Opioids Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Australia: Opioids Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Australia: Opioids Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Indonesia: Opioids Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Indonesia: Opioids Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Others: Opioids Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Others: Opioids Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Europe: Opioids Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Europe: Opioids Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Germany: Opioids Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Germany: Opioids Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: France: Opioids Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: France: Opioids Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: United Kingdom: Opioids Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: United Kingdom: Opioids Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Italy: Opioids Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Italy: Opioids Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Spain: Opioids Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Spain: Opioids Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Russia: Opioids Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Russia: Opioids Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Others: Opioids Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Others: Opioids Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Latin America: Opioids Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Latin America: Opioids Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: Brazil: Opioids Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 79: Brazil: Opioids Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 80: Mexico: Opioids Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 81: Mexico: Opioids Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 82: Others: Opioids Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 83: Others: Opioids Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 84: Middle East and Africa: Opioids Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 85: Middle East and Africa: Opioids Market: Breakup by Country (in %), 2025
  • Figure 86: Middle East and Africa: Opioids Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 87: Global: Opioids Industry: SWOT Analysis
  • Figure 88: Global: Opioids Industry: Value Chain Analysis
  • Figure 89: Global: Opioids Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Opioids Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Opioids Market Forecast: Breakup by Product Type (in Million USD), 2026-2034
  • Table 3: Global: Opioids Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: Opioids Market Forecast: Breakup by Distribution Channel (in Million USD), 2026-2034
  • Table 5: Global: Opioids Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Opioids Market: Competitive Structure
  • Table 7: Global: Opioids Market: Key Players